扫描下面的二维码:

二维码

"中文幻灯"标签列表

Metabolic syndrome in the treatment of chronic hepatitis C2008-04-30

APASL consensus statements on ACLF2008-04-30

An Update On Cholangiocarcinoma 2008-04-30

Implications for the Use of Quantitative HBeAg as a Predictive Tool for Treatment Outcome2008-04-30

Current Challenges in Surgical Therapy of HCC Pr Jacques BELGHITI2008-04-29

Interferons,the Backbone of CHC Therapy:Today and Tomorrow2008-04-29

Improving Treatment Response in Chronic HCV2008-04-29

Bile acids enhance genotype 1 HCV replication2008-04-29

Improving Health-Related Quality of Life in CHC Patients: Can We Improve the Status Quo?2008-04-29

In Vitro Activity and Pharmacologic Properties of Two Novel Series of HCV Protease Inhibitors2008-04-29

New Direct Antivirals and Interferon:An Evolving Paradigm2008-04-29

Low level of resistance,low viral fitness and absence of resistance mutations2008-04-29

Role of progenitor cells in liver cancer 2008-04-29

Caner Stem Cells and Liver Caner Cell Biology of CSC 2008-04-29

rebavirin concentration at week four is an independend predictor for sustained virologital response 2008-04-25

Non-alcoholic Fatty liver disease(nafld)is associated with higher overall mortality2008-04-25

Strategies to overcome drug resistance in hepatitis C therapies2008-04-25

188铼-碘化油乳化剂经导管动脉栓塞术治疗肝癌:兔VX2癌模型的试验性研究2008-04-22

HBV的分子病毒学与抗病毒药物耐药2008-04-22

肝纤维化的肾素血管紧张素系统/NADPH氧化酶系统2008-04-22

推荐标签 更多 >>

栏目标签

领域标签



设为首页 | 加入收藏 | 网站地图 | 订阅杂志 | 关于我们 | 版权声明 | 联系方式|招贤纳士
国际肝病  版权所有  京ICP备15060708号   (京)-非经营性-2016-0001京公网安备 11010502033341号 2004-2020  www.ihepa.com  ALL Rights  Reserved

增值电信业务经营许可证:京B2-20212326

网站统计